title: Biology description: What graphene-family sheets do in cells, microbes, plants, and tissue. Goals, theories, projections — labeled. Not a treatment page. tags:
- medical
- biology
Parent: medical. Exposure numbers and human protocols: health. Form still decides the result: forms.
Already on this archive
- Form × route matrix. form-route
- Occupational and small-human effects. effects
- Andrews 2024 / NCT03659864 GO inhalation — acute physiology, not ecology.
- Rodent high-dose lung inflammation / fibrosis trend in some designs — size, oxidation, metals, respirable fraction. Same effects page.
- In-vitro antibacterial / antiviral GO pile — large, condition-dependent. biomedical-catalogue
- GO as a carrier in cells and rodents (small-molecule, photothermal ideas) — delivery papers, not licensed drugs.
Goals people write down
- A sheet that a cell treats as inert at a useful dose.
- A sheet that a microbe does not ignore (antibacterial coatings, filter media — zenguard is a coat, not a drug).
- Fate and clearance maps for GO vs rGO vs GNP after lung, gut, or skin contact.
- Plant and soil studies that survive a second lab.
Theories in circulation
- “Pencil lead, therefore biology is done.” Ignores GO vs monolayer vs powder. misconceptions
- “One IC50 in a dish predicts a workplace or a vaccine.” Wrong evidence class. fringe
- Oxidative-stress / sharp-edge cutting as the mechanism. Real papers exist; they do not collapse to one slogan.
- Bioaccumulation as a cover-up story. Documented on conspiracies, not here as fact.
Projections (forecast language)
Reviews keep projecting biodegradable graphene, DNA–graphene scaffolds, and “green” GO from biomass. Treat as slides until there is an NCT number or a regulator text. Market-size “graphene healthcare” figures stay unsourced unless the house and the definition are quoted.
New biology row needs: form, species or system, dose, endpoint, primary.